SIO and AstraZeneca Announce Grant Recipients
SIO and AstraZeneca announce their 2023 Combined Locoregional and Immunotherapy of HCC Research grant recipients. The investigators and project proposals that have been awarded grants include:
Elif Öcal
LMU University Hospital Munich
Spatial proteogenomics for prediction of response in combined radioembolization and immunotherapy of HCC
Christopher D. Malone
Mallinckrodt Institute of Radiology at Washington University School of Medicine
Understanding the Influence of Hepatocellular Carcinoma Tumor Immune Microenvironment on Response to Y-90 Radioembolization and Potential Combinations with Immune Checkpoint Inhibition
SIO and AstraZeneca Announce Grant Recipients
SIO and AstraZeneca announce their 2022 Combined Locoregional and Immunotherapy of HCC Research grant recipients. The investigators and project proposals that have been awarded grants include:
Professor S. Nahum Goldberg
Hadassah Hebrew University
Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC
Isabel Newton
VA San Diego Healthcare System and UCSD Health
Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant and Checkpoint Inhibitors
Kiyoyuki Minamiguchi
University of Texas MD Anderson Cancer Center
Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer
David Tischfield and Kelley Weinfurtner
University of Pennsylvania
Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy of HCC
SIO and Guerbet, LLC Announce Grant Recipients
The Society of Interventional Oncology (SIO) and Guerbet LLC announce their 2018 transarterial Lipiodol® chemoembolization grant recipients. The investigators and project proposals that have been awarded grants include:
F. Edward Boas
Memorial Sloan Kettering Cancer Center
Phase I Study of Transarterial Chemoembolization of Lung Metastases
Julius Chapiro
Yale University School of Medicine
Molecular Imaging of the Tumor Microenvironment and Immune Response in TACE
Terence Gade
Hospital of the University of Pennsylvania
Targeting the Metabolic Stress Response in Hepatocellular Carcinoma
Anil K. Pilla
University of Texas Health Science Center at Houston
Identify Proteomic Biomarkers for Outcome Prediction of Lipiodol® TACE Treatment
SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program
The Society of Interventional Oncology (SIO) and BTG plc (LSE: BTG) announce their 2018 Interventional Oncology/Immuno-Oncology research grant recipients. The investigators and project proposals that have been awarded grants include:
Rony Avritscher
University of Texas MD Anderson Cancer Center
Strategies to Modulate Liver Tumor Immune Microenvironment after Catheter-based Drug Delivery
Terence Gade, University of Pennsylvania
University of Pennsylvania
Characterization of the Immunobiologic Response Following Transarterial Chemoembolization of HCC
Samdeep Mouli
Northwestern University
Y90 Radioembolization Combined with Immune Checkpoint Blockade in an Animal Model of Hepatocellular
Isabel Newton
University of California, San Diego
Effects of Cryoablation on Hepatocellular Carcinoma Cancer Stem Cells and the Immune Response
Paul Thevenot
Ochsner Health System
Tumor-Induced Tolerance in Driving Embolization Resistance and Waitlist/Transplant Outcomes